Vosoritide · source year
6 selected, source-linked Vosoritide records carrying a 2025 source date. This is a navigational view of PeptideScanner’s selected coverage—not a complete research timeline or a statement about safety or effectiveness.
6 selected records.
3 represented types.
6 distinct public records.
Cited chronology
Literature metadata
PubMed lists PMID 41340868 in Genetics in medicine open as Journal Article, with publication-date metadata of 2025-10-13 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Source: PubMed ↗
Regulatory
The Federal Register published notice 2025-22131, attributed to FDA and its parent HHS department, on 2025-12-05. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon, Liraglutide, Semaglutide, Teriparatide, Tirzepatide and Vosoritide.
Source: Federal Register via GovInfo ↗
Regulatory
DailyMed lists Structured Product Labeling version 16 for the reviewed Vosoritide label family with a published date of 2025-11-26. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Literature metadata
PubMed lists PMID 41078071 in Hormone research in paediatrics as Case Reports, Journal Article, with publication-date metadata of 2025-10-10 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Source: PubMed ↗
Literature metadata
PubMed lists PMID 40821249 in Cureus as Journal Article, Review, with publication-date metadata of 2025-07-15 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Source: PubMed ↗
Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT07073014 at 2026-07-30T18:24:37.179Z. Its registry update date was 2025-07-18, and PeptideScanner's reviewed identity mapping was vosoritide.
Source: ClinicalTrials.gov ↗